QA: Lumos Pharma INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001126234_2023_Lumos_Pharma_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 1523000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001126234, Lumos Pharma INC

  xvar xval
0 AssetsCurrent 72,009,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 53,000
3 remainder_Assets 230,000
4 LiabilitiesCurrent 6,708,000
5 LiabilitiesNoncurrent 6,000,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,714,588
9 ResearchAndDevelopmentExpense 17,750,505
10 remainder_Expenses -160,460
11 remainder_Revenues 1,520,137
12 remainder_NetIncome 722,135
13 remainder_ComprehensiveNetIncome -8,999
  yvar yval
0 Assets 72,292,000
1 Liabilities 12,708,000
2 Expenses 33,304,633
3 Revenues 1,520,137
4 StockholdersEquity 59,584,000
5 NetIncome -31,062,361
6 ComprehensiveNetIncome -31,066,860
7 BaseVar 60,277,952
8 EconomicCapitalRatiobeforeLimitedLiability 2.33
9 EconomicCapitalRatio 3.24

Edgar->Model Mapping

Feature Distribution

Change over Time